BioSpace News Archive

Biotech Bay

Marrone Bio Innovations Announces Availability of Next Generation Grandevo WDG Bioinsecticide in California

The industry recognizes NOW as the primary pest in pistachios and almonds.

January 10, 2018
·
5 min read
Pharm Country

Precipios: Yale Study Demonstrates Four-Fold Superiority of Academic Level Diagnostic Accuracy

Study further shows ~73% of cases which academic pathologists determined were previously misdiagnosed, have definite or possible material impact on patient treatment plans.

January 10, 2018
·
7 min read
Business

PositiveID Announces 2017 Highlights and Projects Continued 30% Growth

Company expects year-over-year growth of over 30% for the 2017 fourth quarter and 2018 first quarter.

January 10, 2018
·
7 min read
Drug Development

Avadel Pharmaceuticals Receives Orphan Drug Designation From FDA for FT 218 for the Treatment of Narcolepsy

The designation has been granted on the plausible hypothesis that FT 218 may be clinically superior to the same drug already approved for the same indication.

January 10, 2018
·
5 min read
Drug Development

Atara Biotherapeutics Announces FDA Clearance to Proceed With Enrollment at U.S. Sites for Ongoing Global Phase I Clinical Study to Evaluate ATA188 in Patients With Progressive or Relapsing-Remitting Multiple Sclerosis

The primary objective of Atara’s ongoing Phase 1 clinical study is to assess the safety of ATA188 in patients followed for at least one year after the first dose.

January 10, 2018
·
7 min read
Evogene Announces Positive 2nd Year Field Trial Results in Corn Bio-Stimulant Ag-Biologicals Program

Results demonstrated significant yield improvement; selected microbial strains to be tested as part of the collaboration with DuPont-Pioneer.

January 10, 2018
·
4 min read
Business

Basilea Announces Completion of the License Agreement Extension With Pfizer for Antifungal Cresemba for China and Asia Pacific

The amendment was subject to customary regulatory review which has completed. Isavuconazole is an antifungal for the treatment of life-threatening invasive mold infections.

January 10, 2018
·
4 min read
Drug Development

GenSight Biologics Receives MHRA Approval to Initiate Phase I/II PIONEER Clinical Trial of GS030 Gene Therapy in Retinitis Pigmentosa

The primary outcome analysis will be the safety and tolerability at one year post-injection.

January 10, 2018
·
5 min read
Biotech Beach

AmpliPhi Biosciences Announces Pricing of $4.0 Million Public Offering of Common Stock

The offering is expected to close on or about January 12, 2018, subject to customary closing conditions.

January 10, 2018
·
4 min read
Business

Cardiovascular Systems to Webcast Fiscal 2018 Second-Quarter Earnings Conference Call Wednesday, February 7

Scott Ward, Chairman, President and Chief Executive Officer, and Larry Betterley, Chief Financial Officer, will discuss CSI’s results for its fiscal second quarter ended December 31, 2017, and its financial outlook.

January 10, 2018
·
1 min read